With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product ...
CMS released its proposed CY 2027 Medicare Physician Fee Schedule July 14, setting up another cycle of physician pay cuts at the same time the companion CY 2027 OPPS/ASC proposed rule moves facility ...
ASCRS issued a statement supporting the continued use of 2 Category I CPT codes for cyclodialysis with scleral reinforcement.
New research on tirzepatide, the drug behind Zepbound and Mounjaro, suggests it could significantly lower the risk of major cardiovascular event. Tirzepatide, the drug behind blockbuster treatments ...
A new clinical classification scheme is presented, entitled “Acute Pulmonary Embolism Clinical Categories,” with 5 categories (A-E) and subcategories, ranging from low to high risk for adverse ...
MSN via Barron Kerry Stewart, an exercise physiologist and professor of medicine at Johns Hopkins, says exercise capacity "definitely declines" as we age. "With regular exercise, the decline won't be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results